2-Amino-4-phenylbutane, commonly known as racemic β-phenylisopropylamine or simply phenylisopropylamine (PIA), is a chemical compound with potential applications in the pharmaceutical industry. This article aims to provide detailed information on PIA, including its chemical name, molecular formula, formula weight, CAS number, top keywords from Google searches, synonyms, health benefits, potential effects, product mechanism, safety, side effects, and dosing information.
Chemical name:
The chemical name for PIA is 2-amino-4-phenylbutane.
Molecular formula:
The molecular formula for PIA is C10H15N.
Formula weight:
The formula weight of PIA is 149.24 g/mol.
CAS No:
The CAS number for PIA is 22374-89-6.
Top ten keywords from Google searches:
Synonyms:
PIA is also known by several other names, including β-phenylisopropylamine, N-isopropylbenzylamine, and N-benzylisopropylamine.
Health benefits of this product:
There are no known health benefits of PIA. However, it has been studied for its potential use in the development of various drugs that have been shown to be effective in treating conditions such as obesity, depression, and attention deficit hyperactivity disorder (ADHD).
Potential effects:
PIA has been shown to have potential stimulant properties, making it a promising candidate for the treatment of conditions such as ADHD. It has also been studied for its potential anorectic and antidepressant effects, which may make it an important component in the development of drugs used to treat obesity and depression.
Product mechanism:
The exact mechanism of action of PIA is not fully understood. However, studies have suggested that it may exert its therapeutic effects by acting as a dopamine and norepinephrine reuptake inhibitor or by modulating neurotransmitter systems in the brain.
Safety:
Limited information is available on the safety of PIA. It is essential to handle the compound with care and use appropriate personal protective equipment while handling it to avoid any potential hazards.
Side effects:
As with the safety profile, limited information is available on the potential side effects of PIA. However, some studies have suggested that it may have potential neurotoxic effects, indicating the need for further investigation into its safety profile.
Dosing information:
There is no specific dosing information available for PIA. The dosage would depend on the type of medical condition being treated and should be determined by a qualified healthcare professional.
Conclusion:
In conclusion, PIA is a chemical compound with potential applications in the pharmaceutical industry. While its exact mechanism of action and safety profile are not fully understood, the compound's potential stimulant, anorectic, and antidepressant effects make it an interesting candidate for further study. Future research will help to elucidate its mechanism of action, safety profile, and pharmacological properties, which will be important in determining its potential use as a therapeutic agent
